CHICAGO — Administering the bispecific antibody amivantamab (Rybrevant) subcutaneously rather than intravenously in combination with lazertinib (Leclaza) not only reduces administration times but also may offer […]
Nearly 2 years after their final transfusion with the IGF-IR inhibitor teprotumumab (Tepezza), 82% of patients with thyroid eye disease did not need further treatment for […]
Insurance companies frequently deny insurance coverage of glucagon-like peptide-1 (GLP-1) receptor agonists for adolescents, according to a new analysis. For those whose GLP-1 prescriptions were covered, […]
BOSTON — Crinecerfont, an investigational oral selective corticotropin-releasing factor type 1 receptor antagonist, benefits both adults and children with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase […]
The glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Ozempic, Wegovy) enhances taste sensitivity, changes brain responses to sweet tastes, and may even alter expression of genes in […]
Two common cost-containment strategies — high-deductible health plans and stringent prior authorization requirements — can significantly hinder the survival and well-being of patients with cancer, according […]
CHICAGO — The benefit observed with lorlatinib (Lorbrena) in 5-year follow-up data from the CROWN trial corresponds to the longest progression-free survival (PFS) reported for any […]
A conversational artificial intelligence patient navigator was successful at re-engaging patients in colonoscopy screening, essentially doubling the colonoscopy completion rate in patients from underserved communities who […]
Share on PinterestGLP-1 drugs like Ozempic and Wegovy may affect your sense of taste and the way your brain responds to sweet foods. Tom Werner/Getty Images […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.